Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden
- 17 May 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 15 (11) , 1807-1815
Abstract
Rates of obesity are rising in patients with inflammatory bowel disease. (IBD). We conducted a United States population-based study to determine the effects of obesity on outcomes in hospitalized patients with IBD. We searched the Nationwide Readmissions Database from 2016-2017 to identify all adult patients hospitalized for IBD using ICD-10 codes. We compared obese (BMI ≥30) vs. non-obese (BMI <30) patients with IBD to evaluate the independent effects of obesity on readmission, mortality, and other hospital outcomes. Multivariate regression and propensity matching were performed. We identified 143,190 patients with IBD, of whom 9.1% were obese. Obesity was independently associated with higher all-cause readmission at 30- (18% vs 13% [aOR 1.16, p=0.005]) and 90-days (29% vs 21% [aOR 1.27, p<0.0001]), as compared to non-obese patients, with similar findings upon a propensity matched sensitivity analysis. Obese and non-obese patients had similar risks of mortality on index admission (0.24% vs 0.31%, p=0.18), and readmission (1.5% vs 1.8% p=0.3). Obese patients had longer (5.3 vs 4.9 days) and more expensive ($12,195 vs $11,154) hospitalizations on index admission. Obesity did not affect the risk of intestinal surgery or bowel obstruction. Compared to index admissions, readmissions were characterized by increased mortality (6-fold), healthcare use, and bowel obstruction (3-fold) (all p<0.0001). Obesity in IBD appears to be associated with increased early readmission, characterized by a higher burden, despite the introduction of weight-based therapeutics. Prevention of obesity should be a focus in the treatment of IBD to decrease readmission and healthcare burden.Keywords
This publication has 39 references indexed in Scilit:
- A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humansNutrition Research, 2014
- Bacterial Translocation – Impact on the Adipocyte CompartmentFrontiers in Immunology, 2014
- The Increasing Weight of Crohnʼs Disease Subjects in Clinical TrialsInflammatory Bowel Diseases, 2013
- Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010Clinical Gastroenterology and Hepatology, 2013
- Surgical Site Infections and Cost in Obese Patients Undergoing Colorectal SurgeryYearbook of Surgery, 2012
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewGastroenterology, 2012
- Is Obesity a Risk Factor for Crohn’s Disease?Digestive Diseases and Sciences, 2011
- Macrophages, Inflammation, and Insulin ResistanceAnnual Review of Physiology, 2010
- Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel diseaseInflammatory Bowel Diseases, 2006
- Crohn's disease clinical course and severity in obese patientsClinical Nutrition, 2002